Log In
Print
BCIQ
Print
Print this Print this
 

trastuzumab (Subcutaneous Herceptin)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionSubcutaneous formulation of humanized mAb against epidermal growth factor receptor 2 (EGFR2; HER2; ErbB2; neu)
Molecular Target Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu)
Mechanism of ActionAntibody
Latest Stage of DevelopmentRegistration
IndicationBreast cancer
Partner

Chugai Pharmaceutical Co. Ltd.; Genentech Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today